摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯-2-氟-6-碘苯胺 | 216393-67-8

中文名称
4-氯-2-氟-6-碘苯胺
中文别名
2-氟-4-氯-6-碘苯胺
英文名称
4-chloro-2-fluoro-6-iodoaniline
英文别名
——
4-氯-2-氟-6-碘苯胺化学式
CAS
216393-67-8
化学式
C6H4ClFIN
mdl
——
分子量
271.46
InChiKey
SSNQXCONXNVTJN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    39-41°C
  • 沸点:
    267.4±40.0 °C(Predicted)
  • 密度:
    2.089±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    避免接触氧化物和光线。

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R20/21/22,R36/38
  • 海关编码:
    2921420090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险品运输编号:
    2811
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H317,H319
  • 储存条件:
    保存方法:密闭存放于阴凉、通风干燥处。

SDS

SDS:564b338963bd20eb6c51e1557e173d7e
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Chloro-2-fluoro-6-iodoaniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H331: Toxic if inhaled
H302: Harmful if swallowed
H312: Harmful in contact with skin
H315: Causes skin irritation
H319: Causes serious eye irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P304+P340:
P405: Store locked up

Section 3. Composition/information on ingredients.
Ingredient name: 4-Chloro-2-fluoro-6-iodoaniline
CAS number: 216393-67-8

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H4ClFIN
Molecular weight: 271.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride, hy-
drogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (4-Chloro-2-fluoro-6-iodoaniline)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氯-2-氟-6-碘苯胺盐酸 、 sodium nitrite 、 sodium azide 作用下, 以 为溶剂, 反应 0.83h, 生成 2-azido-5-chloro-1-fluoro-3-iodobenzene
    参考文献:
    名称:
    Pd / C催化由2-碘代芳基叠氮化物和胺类化合物合成2-氨基苯并恶嗪酮
    摘要:
    已经开发了钯催化的由1-叠氮基-2-碘苯和胺合成2-氨基苯并恶嗪酮的羰基化方法。通过在CO气氛下使用Pd / C作为催化剂,以中等到极好的收率制备了各种各样的2-氨基苯并恶嗪酮衍生物。特别地,通过使用有机叠氮化物作为底物,可以成功地避免外部氧化剂的使用,并且仅形成副产物N 2。
    DOI:
    10.1021/acs.orglett.9b00966
  • 作为产物:
    描述:
    4-氯-2-氟苯胺 、 silver sulfate 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以40%的产率得到4-氯-2-氟-6-碘苯胺
    参考文献:
    名称:
    Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
    摘要:
    这项发明提供了具有以下一般式的新化合物: 其中R1、R2、R3、R4、R5、R7、A1、A2和A3如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
    公开号:
    US20160200741A1
点击查看最新优质反应信息

文献信息

  • [EN] NEW ARYL-QUINOLINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'ARYLQUINOLÉINE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2013064465A1
    公开(公告)日:2013-05-10
    The invention provides novel compounds having the general formula (I), wherein R1, R2, R3, R4 R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds.
    本发明提供了具有通用公式(I)的新颖化合物,其中R1、R2、R3、R4、R5、R6和n如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
  • [EN] INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] DÉRIVÉS D'INDOLAMIDE ET COMPOSÉS ASSOCIÉS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
    申请人:UNIV LEUVEN KATH
    公开号:WO2010142801A1
    公开(公告)日:2010-12-16
    This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.
    本发明提供了新型化合物,以及这些新型化合物作为药物的使用,特别是用于预防或治疗神经退行性疾病,更具体地是一些神经系统疾病,例如统称为tauopathies的疾病,以及以细胞毒性α-突触核蛋白淀粉样蛋白生成为特征的疾病。本发明还涉及将所述新型化合物用于制造用于治疗此类神经退行性疾病的药物。本发明还涉及包括所述新型化合物的药物组合物,以及制备所述新型化合物的方法。
  • Palladium-Catalyzed Cyclization Reaction of <i>o</i>-Iodoanilines, CO<sub>2</sub>, and CO: Access to Isatoic Anhydrides
    作者:Wen-Zhen Zhang、Ning Zhang、Yu-Qian Sun、Yu-Wei Ding、Xiao-Bing Lu
    DOI:10.1021/acscatal.7b03000
    日期:2017.12.1
    oxidants. Herein we report a highly selective palladium-catalyzed cyclization reaction for the efficient synthesis of isatoic anhydrides from readily available o-iodoanilines, CO2, and CO. The reaction proceeds under mild conditions and is redox-neutral. Both CO2 and CO are indispensable C1 building blocks for this catalytic reaction.
    通常使用高毒性的光气或化学计量的氧化剂来制备一类酸酐,一类有价值的合成中间体和RNA结构探测试剂。本文中,我们报道了一种高度选择性的钯催化环化反应,用于从容易获得的邻碘代苯胺,CO 2和CO有效合成isatoic酸酐。该反应在温和的条件下进行,并且是氧化还原中性的。对于该催化反应,CO 2和CO都是不可或缺的C1结构单元。
  • A Palladium-Catalyzed Double Carbonylation Approach to Isatins from 2-Iodoanilines
    作者:Simon R. Laursen、Mikkel T. Jensen、Anders T. Lindhardt、Mikkel F. Jacobsen、Troels Skrydstrup
    DOI:10.1002/ejoc.201600143
    日期:2016.4
    A high-yielding procedure for the synthesis of isatins has been developed. Sequential Pd-catalyzed double carbonylation of 2-iodoanilines with near stoichiometric amounts of CO followed by acid-promoted cyclization readily affords an array of isatins. The conversion of 2-iodoanilines to isatins in good to excellent yields was found to proceed with good functional group tolerance. This protocol proved
    已开发出合成靛红的高产程序。用接近化学计量的 CO 对 2-碘苯胺进行连续 Pd 催化双羰基化,然后进行酸促进环化,很容易得到一系列靛红。发现 2-碘苯胺以良好到极好的产率转化为靛红,具有良好的官能团耐受性。该协议证明适用于靛红的 13C 同位素标记, 并扩展到 13C 同位素标记的抗病毒药物美替沙宗和实验性抗精神分裂症药物 ML137 的合成。
  • [EN] NEW COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] NOUVEAUX COMPOSÉS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
    申请人:UNIV LEUVEN KATH
    公开号:WO2012080221A1
    公开(公告)日:2012-06-21
    This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds. The compounds have the formula (A1) wherein R1, R2, R4, R6, E, n, Y1, Y2, Y3, Y4, Y5, L, B, R8, and m are as defined in the claims.
    本发明提供了新型化合物,以及这些新型化合物作为药物的使用,特别是用于预防或治疗神经退行性疾病,更具体地是一些神经系统疾病,例如统称为tauopathies的疾病,以及以细胞毒性α-突触核蛋白淀粉样生成特征的疾病。本发明还涉及将所述新型化合物用于制造用于治疗此类神经退行性疾病的药物。本发明进一步涉及包括所述新型化合物的药物组合物以及制备所述新型化合物的方法。这些化合物的公式为(A1),其中R1、R2、R4、R6、E、n、Y1、Y2、Y3、Y4、Y5、L、B、R8和m如权利要求中所定义。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐